| Literature DB >> 8164455 |
J Y Follezou1, L Chauveinc, J M Guerin.
Abstract
The mechanism of the transient encephalopathy induced by high dose systemic administration of methotrexate (HDMTX) is unknown. Metabolic and vascular hypothesis have been formulated but convincing evidence is lacking. We report the first case of vascular disturbances (thinness of cortical arteries on angiography, reversible fall down of cerebral flow and increase of carotid resistance) in a young Algerian patient treated for an osteogenic osteosarcoma. This observation might lead to the exploration by non invasive and easily repeatable techniques of the cerebral vascular dynamic in patients submitted to HDMTX and thus contributed to the elucidation of the mechanism and to the prevention of these neurological side effect.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8164455 DOI: 10.1007/bf02989667
Source DB: PubMed Journal: Med Oncol Tumor Pharmacother ISSN: 0736-0118